- 文档语言：英文
- 文档大小：9KB
- 文档类型：PPT
- 发布时间：2017/6/9 14:45:07
- 相关网站：internet
-
下载
- 版权说明：本站所有资源来源于网络，版权为原作者所有，本站刊载，仅限于促进医药行业发展、科技进步之目的。如本站行为侵犯了您的合法权益，请来信告知，我们将妥善处理。给您带来不便，敬请原谅。
- 幻灯介绍：
Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions
Statins 0.69 (0.59-0.80)
n=13 (16,228/11,279)
n-3 fatty acids 0.44 (0.18-1.07)
n=3 (1,348/1,349)
Fibrates 0.98 (0.78-1.24)
n=12 (9,873/11,496)
Resins 0.71 (0.51-0.99)
n=8 (3,280/3,257
Hormones 1.04 (0.93-1.17)
n=8 (4,516/9,039)
Niacin acids 0.85 (0.83-1.10)
n=2 (1,196/2,932)
Diet 0.91 (0.82-1.01)
n=16 (48,481/59,042)
1.0
.9
.8
.7
.6
.5
.4
.3
.2
.1
2
Risk Ratio % 95% CI
Benefit
Harm
Arterioscler Thromb Vasc Biol. 1999;19:187-195
Risk Ratio for Overall Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions
Statins 0.79 (0.71-0.89)
n=13 (16,228/11,279)
n-3 fatty acids 0.66 (0.53-0.88)
n=3 (1,348/1,349)
Fibrates 1.06 (0.78-1.48)
n=12 (9,873/11,496)
Resins 0.85 (0.66-1.08)
n=8 (3,280/3,257
Hormones 1.09 (1.00-1.20)
n=8 (4,516/9,039)
Niacin acids 0.96 (0.86-1.08)
n=2 (1,196/2,932)
Diet 0.97 (0.81-1.15)
n=16 (48,441/59,042)
1.0
.9
.8
.7
.6
.5
.4
2
Risk Ratio % 95% CI
Benefit
Harm
Arterioscler Thromb Vasc Biol. 1999;19:187-195
Risk Ratio for Mortality Other Than From CHD in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions
Statins 0.97 (0.81-1.16)
n=13 (16,228/11,279)
n-3 fatty acids 1.16 (0.63-2.12)
n=3 (1,348/1,349)
Fibrates 1.16 (0.63-2.12)
n=12 (9,873/11,496)
Resins 1.07 (0.74-1.55)
n=8 (3,280/3,257
Hormones 1.29 (1.08-1.57)
n=8 (4,516/9,039)
Niacin acids 0.99 (0.76-1.29)
n=2 (1,196/2,932)
Diet 1.00 (0.95-1.05)
n=16 (48,481/59,042)
1.0
.9
.8
.7
.6
2
Risk Ratio % 95% CI
Benefit
Harm
Arterioscler Thromb Vasc Biol. 1999;19:187-195
3